171 related articles for article (PubMed ID: 22068196)
1. Does bargaining affect Medicare prescription drug plan reimbursements to independent pharmacies?
Tang Y; Xie Y; Urmie JM; Doucette WR
J Am Pharm Assoc (2003); 2011; 51(6):738-45. PubMed ID: 22068196
[TBL] [Abstract][Full Text] [Related]
2. Retail pharmacy market structure and insurer-independent pharmacy bargaining in the Medicare Part D era.
Xie Y; Brooks JM; Urmie JM; Doucette WR
Adv Health Econ Health Serv Res; 2010; 22():295-316. PubMed ID: 20575238
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
[TBL] [Abstract][Full Text] [Related]
4. Services provided by community pharmacies in Wayne County, Michigan: a comparison by ZIP code characteristics.
Erickson SR; Workman P
J Am Pharm Assoc (2003); 2014; 54(6):618-24. PubMed ID: 25379982
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting bargaining outcomes between pharmacies and insurers.
Brooks JM; Doucette W; Sorofman B
Health Serv Res; 1999 Apr; 34(1 Pt 2):439-51. PubMed ID: 10199687
[TBL] [Abstract][Full Text] [Related]
6. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
7. Third party bargaining and contract terms: a link over time?
Brooks JM; Doucette WR; Sorofman BA
J Am Pharm Assoc (Wash); 2002; 42(3):420-7. PubMed ID: 12030628
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the claim percent gross margin earned by Texas community independent pharmacies for dual-eligible beneficiary claims before and after Medicare Part D.
Winegar AL; Shepherd MD; Lawson KA; Richards KM
J Am Pharm Assoc (2003); 2009; 49(5):617-22. PubMed ID: 19748868
[TBL] [Abstract][Full Text] [Related]
9. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
10. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
Bono JD; Crawford SY
Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
[TBL] [Abstract][Full Text] [Related]
11. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
12. Cost minimization of medicare part D prescription drug plan expenditures.
Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
[TBL] [Abstract][Full Text] [Related]
13. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
[TBL] [Abstract][Full Text] [Related]
14. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
15. Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study.
Luo J; Kulldorff M; Sarpatwari A; Pawar A; Kesselheim AS
Ann Intern Med; 2019 Nov; 171(9):605-611. PubMed ID: 31569218
[TBL] [Abstract][Full Text] [Related]
16. Estimating the impact of Medicare part D on the profitability of independent community pharmacies.
Carroll NV
J Manag Care Pharm; 2008 Oct; 14(8):768-79. PubMed ID: 18983206
[TBL] [Abstract][Full Text] [Related]
17. Potential opportunity cost of neglecting to annually reassess Medicare Part D standalone prescription drug plan offerings: the price of contentment?
Walberg MP; Patel RA
J Am Pharm Assoc (2003); 2009; 49(6):777-82. PubMed ID: 19926558
[TBL] [Abstract][Full Text] [Related]
18. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.
Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ
N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795
[TBL] [Abstract][Full Text] [Related]
19. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
Bazalo G; Weiss RC
Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
[TBL] [Abstract][Full Text] [Related]
20. Drug plan design incentives among Medicare prescription drug plans.
Huskamp HA; Keating NL; Dalton JB; Chernew ME; Newhouse JP
Am J Manag Care; 2014 Jul; 20(7):562. PubMed ID: 25295402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
